1. Exploring Dysregulated Signaling Pathways in Cancer
   Sabah Nisar et al, 2020, Current Pharmaceutical Design CrossRef
2. Recent Advances in Oral Cancer Research
   Deepika Mishra et al, 2021, Management of Oral Cancers CrossRef
3. Serum CRIPTO does not confer drug resistance against osimertinib but is an indicator of tumor burden in non-small cell lung cancer
   Vincent Chen et al, 2020, Lung Cancer CrossRef